235 related articles for article (PubMed ID: 8926281)
1. Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection.
Bélec L; Tévi-Bénissan C; Dupré T; Mohamed AS; Prazuck T; Gilquin J; Kanga JM; Pillot J
J Clin Immunol; 1996 Jan; 16(1):12-20. PubMed ID: 8926281
[TBL] [Abstract][Full Text] [Related]
2. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection.
Bélec L; Dupré T; Prazuck T; Tévi-Bénissan C; Kanga JM; Pathey O; Lu XS; Pillot J
J Infect Dis; 1995 Sep; 172(3):691-7. PubMed ID: 7658060
[TBL] [Abstract][Full Text] [Related]
3. Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection.
Bélec L; Tévi-Bénissan C; Lu XS; Prazuck T; Pillot J
AIDS Res Hum Retroviruses; 1995 Jun; 11(6):719-29. PubMed ID: 7576932
[TBL] [Abstract][Full Text] [Related]
4. Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women.
Lu XS; Bélec L; Pillot J
J Infect Dis; 1993 May; 167(5):1189-92. PubMed ID: 8486953
[TBL] [Abstract][Full Text] [Related]
5. Decreased cervicovaginal production of both IgA1 and IgA2 subclasses in women with AIDS.
Belec L; Meillet D; Gaillard O; Prazuck T; Michel E; Ngondi Ekome J; Pillot J
Clin Exp Immunol; 1995 Jul; 101(1):100-6. PubMed ID: 7621578
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects.
Raux M; Finkielsztejn L; Salmon-Céron D; Bouchez H; Excler JL; Dulioust E; Grouin JM; Sicard D; Blondeau C
AIDS Res Hum Retroviruses; 1999 Oct; 15(15):1365-76. PubMed ID: 10515152
[TBL] [Abstract][Full Text] [Related]
7. Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine. The National Institute of Allergy and Infectious Diseases-sponsored AIDS Vaccine Evaluation Group.
Lambert JS; Viscidi R; Walker MC; Clayman B; Winget M; Wolff M; Schwartz DH
Clin Diagn Lab Immunol; 1997 May; 4(3):302-8. PubMed ID: 9144368
[TBL] [Abstract][Full Text] [Related]
8. Predominate HIV1-specific IgG activity in various mucosal compartments of HIV1-infected individuals.
Lü FX
Clin Immunol; 2000 Oct; 97(1):59-68. PubMed ID: 10998318
[TBL] [Abstract][Full Text] [Related]
9. Cervicovaginal synthesis of IgG antibodies to the immunodominant 175-199 domain of the surface glycoprotein gp46 of human T-cell leukemia virus type I.
Bélec L; Georges-Courbot MC; Georges A; Mohamed AS; Londos-Gagliardi D; Hallouin MC; Hocini H; Guillemain B
J Med Virol; 1996 Sep; 50(1):42-9. PubMed ID: 8890040
[TBL] [Abstract][Full Text] [Related]
10. Cervicovaginal anti-HIV antibodies in index women from HIV-discordant, exclusively heterosexual, couples.
Bélec L; Prazuck T; Payan C; Mohamed AS; Cancre N; Hocini H; Malkin JE; Pillot J
Viral Immunol; 1996; 9(3):155-8. PubMed ID: 8890473
[TBL] [Abstract][Full Text] [Related]
11. Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals.
Mestecky J; Jackson S; Moldoveanu Z; Nesbit LR; Kulhavy R; Prince SJ; Sabbaj S; Mulligan MJ; Goepfert PA
AIDS Res Hum Retroviruses; 2004 Sep; 20(9):972-88. PubMed ID: 15585085
[TBL] [Abstract][Full Text] [Related]
12. New method for quantifying anti-HIV1-gp160 antibodies in saliva, cervicovaginal secretions, and serum of infected women.
Lü FX
J Clin Lab Anal; 2000; 14(4):188-92. PubMed ID: 10906772
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of IgA anti-HIV antibodies in plasma from patients with HIV infection.
Matsuda S; Noda M; Toyota A; Tokumoto S; Miyata M
Microbiol Immunol; 1997; 41(10):785-90. PubMed ID: 9403502
[TBL] [Abstract][Full Text] [Related]
14. Human T-lymphotropic virus type I excretion and specific antibody response in paired saliva and cervicovaginal secretions.
Belec L; Jean Georges A; Hallouin MC; Si Mohamed A; Morand-Joubert L; Georges-Courbot MC
AIDS Res Hum Retroviruses; 1996 Jan; 12(2):157-167. PubMed ID: 8834466
[TBL] [Abstract][Full Text] [Related]
15. Serum IgA subclasses and molecular forms in HIV infection: selective increases in monomer and apparent restriction of the antibody response to IgA1 antibodies mainly directed at env glycoproteins.
Kozlowski PA; Jackson S
AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1773-80. PubMed ID: 1457191
[TBL] [Abstract][Full Text] [Related]
16. HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses.
Sakaue G; Hiroi T; Nakagawa Y; Someya K; Iwatani K; Sawa Y; Takahashi H; Honda M; Kunisawa J; Kiyono H
J Immunol; 2003 Jan; 170(1):495-502. PubMed ID: 12496436
[TBL] [Abstract][Full Text] [Related]
17. IgA immunity in HIV type 1-infected chimpanzees. II. Mucosal immunity.
Black KP; Fultz PN; Girard M; Jackson S
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1273-82. PubMed ID: 9339844
[TBL] [Abstract][Full Text] [Related]
18. IgA immunity in HIV type 1-infected chimpanzees. I. Systemic immunity.
Black KP; Fultz PN; Girard M; Jackson S
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1263-72. PubMed ID: 9339843
[TBL] [Abstract][Full Text] [Related]
19. Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding.
Fiore JR; Laddago V; Lepera A; La Grasta L; Di Stefano M; Saracino A; Lopalco P; Pastore G; Angarano G
New Microbiol; 2000 Jan; 23(1):85-92. PubMed ID: 10946410
[TBL] [Abstract][Full Text] [Related]
20. Mucosal humoral immune response to hepatitis C virus E1/E2 surface glycoproteins and HCV shedding in saliva and cervicovaginal fluids from chronically HCV-infected patients.
Bélec L; Legoff J; Si-Mohamed A; Bloch F; Mbopi Keou FX; Becquart P; Matta M; Prazuck T; Petite JP; Gutmann L; Payan C
J Hepatol; 2003 Jun; 38(6):833-42. PubMed ID: 12763378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
